The following post is reprinted with permission from Paul Karlsgodt’s blog, www.classactionblawg.com.  Stay tuned over the coming days for more in-depth analysis of the Amgen decision and its potential implications for securities class actions and class actions more generally. The Supreme Court has issued its opinion in one of the most highly anticipated class action-related cases on … Continue Reading